AU2089099A - Topical administration of angiotensin-converting enzyme inhibitors - Google Patents

Topical administration of angiotensin-converting enzyme inhibitors

Info

Publication number
AU2089099A
AU2089099A AU20890/99A AU2089099A AU2089099A AU 2089099 A AU2089099 A AU 2089099A AU 20890/99 A AU20890/99 A AU 20890/99A AU 2089099 A AU2089099 A AU 2089099A AU 2089099 A AU2089099 A AU 2089099A
Authority
AU
Australia
Prior art keywords
angiotensin
topical administration
converting enzyme
enzyme inhibitors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20890/99A
Inventor
Michael V. W. Bergamini
John C. Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU2089099A publication Critical patent/AU2089099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU20890/99A 1998-01-16 1998-12-21 Topical administration of angiotensin-converting enzyme inhibitors Abandoned AU2089099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7171498P 1998-01-16 1998-01-16
US60071714 1998-01-16
PCT/US1998/027183 WO1999036062A1 (en) 1998-01-16 1998-12-21 Topical administration of angiotensin-converting enzyme inhibitors

Publications (1)

Publication Number Publication Date
AU2089099A true AU2089099A (en) 1999-08-02

Family

ID=22103107

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20890/99A Abandoned AU2089099A (en) 1998-01-16 1998-12-21 Topical administration of angiotensin-converting enzyme inhibitors

Country Status (2)

Country Link
AU (1) AU2089099A (en)
WO (1) WO1999036062A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794975A1 (en) * 1999-06-16 2000-12-22 Raouf Rekik Ophthalmic medicines having a neuro-protecting and retino-protecting action containing an angiotensin controlling enzyme inhibitor, especially ramipril or ramiprilat
ES2324200T3 (en) * 1999-06-16 2009-08-03 Rekik, Elyes Ben Mohamed Raouf RETINO-PROTECTIVE OPHTHALMOLOGICAL MEDICINES, INCLUDING RAMIPRIL OR RAMIPRILATO.
WO2017077425A1 (en) * 2015-11-07 2017-05-11 Ftf Pharma Private Limited Oral solution of ace inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
EP0114333B1 (en) * 1982-12-27 1990-08-29 Schering Corporation Pharmaceutical composition
US4656188A (en) * 1985-10-09 1987-04-07 Merck & Co., Inc. Ace inhibitors in macular degeneration
JPH10218792A (en) * 1997-02-12 1998-08-18 Santen Pharmaceut Co Ltd Agent for promoting secretion of lacrimation and treating keratoconjunctive disorder containing angiotensin converting enzyme as active ingredient

Also Published As

Publication number Publication date
WO1999036062A1 (en) 1999-07-22

Similar Documents

Publication Publication Date Title
AU3665199A (en) Inhibitors of impdh enzyme
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
AU4172397A (en) Lactam inhibitors of thrombin
AU4429799A (en) Inhibitors of p38
IL138387A0 (en) Enzyme inhibitors
AU5597098A (en) Inhibitors of the enzymatic activity of psa
AU3124300A (en) Inhibitors of beta-lactamases and uses therefor
AU5531599A (en) Novel cdk inhibitors having flavone structure
AU2190400A (en) Inhibitors of beta-lactamases and uses therefor
AU5599598A (en) Inhibitors of glycosyltransferases
AU9059798A (en) Urokinase inhibitors
HUP0101640A3 (en) Certain thoil inhibitors of endothelin-converting enzyme
AU1605699A (en) Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (ii)
AU752953C (en) Adding pharmaceutically active compounds to substrates
AU7125700A (en) Enzyme inhibitors
AU9624398A (en) Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
AU1287100A (en) Peptide inhibitor of browman-birk type
AU2849399A (en) Monobactam enzyme inhibitors
AU5702698A (en) Polyprolyl inhibitors of cyclophilin
AU1013997A (en) Amylase inhibitors
AU6500600A (en) Methods and compositions for determining enzymatic activity
AU2373600A (en) Novel spla2 inhibitors
AU2089099A (en) Topical administration of angiotensin-converting enzyme inhibitors
AU7127000A (en) Enzyme inhibitors
AU8005100A (en) Inhibitors of neuraminidases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase